An Open-Label, Crossover Study In Healthy Volunteers To Evaluate The Pharmacokinetics Of Sildenafil Following Administration Of Three Orally Disintegrating Tablet Formulations Of Sildenafil Without Water Relative To Viagra Conventional Oral Tablet With Water.

NCT00950404 Phase 1 COMPLETED

The bioavailability of the oral disintegrating tablet formulations given without water will be similar to an equivalent dose of the standard oral tablet given with water.

Details

Lead sponsor	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase	Phase 1
Status	COMPLETED
Enrolment	16
Start date	2009-08
Completion	2009-09

Conditions

• Healthy Volunteers

Interventions

• Viagra 50 mg tablet
• Formulation B ODT tablet 50 mg
• Formulation C ODT tablet 50 mg
• Formulation D ODT tablet 50 mg

Primary outcomes

• AUC0-T and Cmax of sildenafil — 1 month

Countries

United States